Your browser doesn't support javascript.
loading
The response to Typhi Vi vaccination is compromised in individuals with primary immunodeficiency.
Kumarage, Jeevani; Seneviratne, Suranjith L; Senaratne, Vijitha; Fernando, Amitha; Gunasekera, Kirthi; Gunasena, Bandu; Gurugama, Padmalal; Peiris, Sudath; Parker, Antony R; Harding, Stephen; de Silva, Nilhan Rajiva.
  • Kumarage J; Department of Immunology, Medical Research Institute, Colombo 8, Sri Lanka.
  • Seneviratne SL; Institute of Immunity and Transplantation, Royal Free Hospital, London, UK.
  • Senaratne V; Department of Surgery, Faculty of Medicine, University of Colombo, Sri Lanka.
  • Fernando A; National Hospital for Respiratory Diseases, Walisara, Sri Lanka.
  • Gunasekera K; National Hospital of Sri Lanka/Central Chest Clinic, Colombo, Sri Lanka.
  • Gunasena B; National Hospital of Sri Lanka/Central Chest Clinic, Colombo, Sri Lanka.
  • Gurugama P; National Hospital for Respiratory Diseases, Walisara, Sri Lanka.
  • Peiris S; Department of Clinical Biochemistry and Immunology, Cambridge University Hospitals NHS Foundation Trust, Hills road, Cambridge, UK.
  • Parker AR; Epidemiology Unit, Ministry of Health, Sri Lanka.
  • Harding S; The Binding Site Group Limited, 8 Calthorpe Road, Edgbaston, Birmingham, B15 1QT, UK.
  • de Silva NR; The Binding Site Group Limited, 8 Calthorpe Road, Edgbaston, Birmingham, B15 1QT, UK.
Heliyon ; 3(6): e00333, 2017 Jun.
Article en En | MEDLINE | ID: mdl-28721392